Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published February 8, 2022

Celebrate Today RED MAMMOTH 400mg Capsules: Unapproved Drug Risk

Celebrate Today recalls 400mg RED MAMMOTH capsules sold with undeclared sildenafil and tadalafil. These unapproved drugs may cause serious health risks. Consumers should stop using and consult a doctor.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0638-2022DrugCelebrate Today ›
Take action

Contact the company

Recalling firmCelebrate Today143 Front Ave · Brentwood, NY 11717-5113
✎ GovInfoNow plain-language explainer

Celebrate Today is recalling 400mg RED MAMMOTH capsules that contain undeclared sildenafil and tadalafil, ingredients approved for male sexual enhancement. This makes the product an unapproved drug that could cause serious health risks. Read more at govinfonow.com/recall/35231-celebrate-today-red-mammoth-400mg-capsules-unapproved-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/35231-celebrate-today-red-mammoth-400mg-capsules-unapproved-drug-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0638-2022

Cite this page

“Celebrate Today RED MAMMOTH 400mg Capsules: Unapproved Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/35231-celebrate-today-red-mammoth-400mg-capsules-unapproved-drug-risk. Based on FDA recall #D-0638-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0638-2022%22&limit=1).

The FDA announced on Feb. 8, 2022, that Celebrate Today recalled RED MAMMOTH capsules for containing undeclared sildenafil and tadalafil. The agency classified the Class I recall as voluntary.

How to tell if you have it

  • Brand: Celebrate Today
  • Product: RED MAMMOTH capsules, 400 mg
  • Packaging: 10-count blisters per carton
  • ASIN: B00KA8FBNI
  • Barcode: X001ANE0I5
  • Lot #: DK1027
  • Expiration: 08/01/2023
  • Quantity: 500 cartons
  • Distribution: Nationwide in the USA via Amazon Marketplace

The hazard

The product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). It contained undeclared sildenafil and tadalafil, ingredients found in FDA-approved products for male sexual enhancement.

Context

GovInfoNow's records show other recent recalls of similar products include StuffbyNainax MR 7 SUPER 700000 Capsules (2025-12-15) and Agebox iKids-Growth Day Formula Capsules (2025-10-28). Buy-Herbal Kian Pee Wan Capsules were also recalled on 2026-03-21 for undeclared drug ingredients.

How to tell if you have this one

Check for RED MAMMOTH capsules, 400mg, in 10-count blister packs per carton. The product has ASIN B00KA8FBNI and barcode X001ANE0I5. Lot # DK1027 expired 08/01/2023.

  • Brand
    Celebrate Today
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled RED MAMMOTH capsules as they contain unapproved drugs that could cause serious health risks.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed nationwide in the USA via Amazon Marketplace” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 49 days after the firm started it.

1. Firm started the recall: Feb 8, 202212. Published in FDA’s Enforcement Report: Feb 23, 202223. FDA classified it Class I: Feb 28, 202234. FDA terminated the recall: Mar 29, 202242022
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Noah's Wholesale THE ROCK Capsules: Unapproved Sildenafil Risk
Noah's Wholesale LLCGadget Island DYNAMITE SUPER Capsules: Unapproved Drug Risk
Gadget IslandStuffbyNainax MR 7 SUPER 700000 Capsules: FDA Finds Undeclared Sildenafil and Tadalafil
StuffbyNainaxAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, Inc

Latest drug recalls

Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A.,
Preferred Pharmaceuticals · September 28, 2026SUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro
Northstar Rx · September 25, 2026Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0638-2022 (February 8, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0638-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA